Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1997-05-08
1999-03-09
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4241921, 4241931, 42419711, 4242001, 435 691, 435 697, 4351723, 43525233, 4353201, 530350, A61K 39095
Patent
active
058796860
ABSTRACT:
The present invention relates, in general, to a method for the high level expression of the outer membrane protein meningococcal group B porin proteins and fusion proteins thereof. In particular, the present invention relates to a method of expressing the outer membrane protein meningococcal group B porin proteins in E. coli wherein the meningococcal group B porin proteins and fusion proteins thereof comprise more than 2% of the total protein expressed in E. coli. The invention also relates to a method of purification and refolding of the meningococcal group B porin proteins and fusion proteins thereof and to their use in vaccines.
REFERENCES:
patent: 4134214 (1979-01-01), Graham et al.
patent: 4271147 (1981-06-01), Helting et al.
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4451446 (1984-05-01), Vandevelde et al.
patent: 4727136 (1988-02-01), Jennings et al.
Ashton et al., "Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide," Microbial Pathog. 6:455-458 (1989).
Barik et al., "Cloning and Expression of the Vesicular Stomatitis Virus Phosphoprotein Gene in Escherichia coli: Analysis of Phosphorylation Status versus Transcriptional Activity", J. Virol. 65(4):1719-1726 (1991).
Barlow et al., "Molecular Cloning and Expression of Neisseria meningitidis Class 1 Outer Membrane Protein in Escherichia coli K-12," Infect. Immun. 55:2734-2740 (1987).
Bjornson et al., "Endotoxin-Associated Protein: A Potent Stimulus for Human Granulocytopoietic Activity Which may be Accessory Cell Independent," Infect. Immun. 56:1602-1607 (1988).
Blake and Gotschlich, "Purification and Partial Characterization of the Opacity-Associated Proteins of Neisseria Gonorrhoeae," J. Exp. Med. 159:452-462 (1984).
Blake et al., "Protein III: Structure, Function, and Genetics," Clin. Microbiol. Rev. 2(Suppl.):S60-S63 (1989).
Boons et al., "Preparation of a Well-Defined Sugar-Peptide Conjugate: A Possible Approach to a Synthetic Vaccine Against Neisseria meningitidis" Bioorganic & Medicinal Chemistry Letters 1:303-308 (1991).
Bremer et al., "Export of a Protein into the Outer Membrane of Escherichia coli K12," Eur. J. Biochem. 122:223-231 (1982).
Bremer et al., "Isolation and characterization of mutants deleted for the sulA-ompA region of the Escherichia coli K-12 chromosome," FEMS Microbiol. Lett. 33:173-178 (1986).
Carbonetti and Sparling, "Molecular cloning and characterization of the structural gene for protein I, the major outer membrane protein of Neisseria gonorrhoeae," Prot. Natl. Acad. Sci. USA 84:9084-9088 (1987).
Cowan et al., "Crystal structures explain functional properties of two E. coli porins," Nature 358:727-733 (Aug. 1992).
Dalbey and Wickner, "Leader Peptidase Catalyzes the Release of Exported Proteins from the Outer Surface of the Escherichia coli Plasma Membrane," J. Biol. Chem. 260:15925-15931 (1985).
De Cock et al., "Assembly of an in Vitro Synthesized Escherichia coli Outer Membrane Porin into Its Stable Trimeric Configuration," J. Biol. Chem. 265:4646-51 (1990).
Eisele and Rosenbusch, "In Vitro Folding and Oligomerization of a Membrane Protein," J. Biol. Chem. 265:10217-10220 (1990).
Feavers et al., "Molecular Analysis of the Serotyping Antigens of Neisseria meningitides," Infect. Immun. 60:3620-3629 (Sep. 1992).
Frasch, C.E., "Production and Control of Neisseria meningitidis Vaccines," in Bacterial Vaccines, Alan R. Liss, Inc. pp. 123-145 (1990).
Frasch et al., "Serotype Antigens of Neisseria meningitidis and a Proposed Scheme for Designation of Serotypes," Rev. Infect. Dis. 7:504-510 (1985).
Freudl et al., "A Lower Size Limit Exists for Export Fragments of an Outer Membrane Protein (OmpA) of Escherichia coli K-12," J. Mol. Biol. 205:771-775 (1985).
Freudl et al., "Cell Surface Exposure of the Outer Membrane Protein OmpA of Escherichia coli K-12," J. Mol. Biol. 188:491-494 (1986).
Freudl et al., "The Signal Sequence Suffices to Direct Export of Outer Membrane Protein OmpA of Escherichia coli K-12," J. Bacteriology 169:66-71 (1987).
Furlong et al., "The Large Subunit of Herpes Simplex Virus Type 1 Ribonucleiotide Reductase: Expression in Escherichia coli and Purification," Virology 182:846-851 (1991).
Gotschlich et al., "The DNA Sequence of the Structural Gene of Gonococcal Protein III and the Flanking Region Containing a Repetitive Sequence," J. Exp. Med. 165:471-482 (1987).
Gotschlich et al., "Gonococcal protein III. Purification and chemical characterization of the protein, and the DNA sequence of the structural gene," Antonie van Leeuwenhoek 53:455-459 (1987).
He et al., "Expression of a Full-Length Nonstructural Protein NS1 of Bluetongue Virus Serotype 17 in Escherichia coli," Biochem. Biophys. Res. Commun. 180:994-1001 (1991).
Holzenburg et al., "Rapid Isolation of OmpF Porin-LPS Complexes Suitable for Structure-Function Studies," Biochemistry 28:4187-4193 (1989).
James et al., "An Improved Method for the Isolation of the Major Protein of the Gonococcal Outer Membrane in an Antigenically Reactive Form," J. Immunol. Meth. 42:223-228 (1981).
Jennings et al., "Determinant Specificities of the Groups B and C Polysaccharides of Neisseria meningiditis" J. Immunol. 134:2651-2657 (1985).
Jennings et al., "Unique Intermolecular Bacterial Epitope Involving the Homosialopolysaccharide Capsule on the Cell Surface of Group B Neisseria meningitidis and Escherichia coli K1," J. Immunol. 142:3585-3591 (1989).
Jennings, H.J., "Capsular Polysaccharides as Vaccine Candidates," Current Topics in Microbiology and Immunology 150:105-107 (1990).
Jones et al., "Resolution of Basic Gonococcal Outer Membrane Proteins by Nonequilibrium pH Gradient Electrophoresis," Infect. Immun. 30:773-780 (1980).
Klose et al., "Internal Deletions in the Gene for an Escherichia coli Outer Membrane Protein Define an Area Possibly Important for Recognition of the Outer Membrane by this Polypeptide," J. Biol. Chem. 263:13291-13296 (1988).
Klose et al., "The Influence of Amino Substitutions within the Mature Part of an Escherichia coli Outer Membrane Protein (OmpA) on Assembly of the Polypeptide into Its Membrane," J. Biol. Chem. 263:13297-13302 (1988).
Kroll et al., "A Multifunctional Prokaryotic Protein Expression Systems: Overproduction, Affinity Purification, and Selective Detection," DNA & Cell Biol. 12(5):441-453 (Jun. 1993).
Lehnhardt et al., "The Differential Effect on Two Hybrid Proteins of Deletion Mutations within the Hydrophobic Region of the Escherichia coli OmpA Signal Peptide," J. Biol. Chem. 262:1716-1719 (1987).
Lin et al., "Expression of Human Factor IX and Its Subfragments in Escherichia coli and Generation of Antibodies to the Subfragment," Biochemistry 26:5267-5274 (1987).
Livingston et al., "GD3/Proteosome Vaccines Induce Consistent IgM Antibodies Against the Ganglioside GD3," Vaccine 11:1199-1204 (Sep. 1993).
Lowell et al., "Peptides Bound to Proteosomes via Hydrophobic Feet Become Highly Immunogenic Without Adjuvants," J. Exp. Med. 167:658-663 (1988).
Lowell et al., "Proteosome-Lipopeptide Vaccines: Enhancement of Immunogenicity for Malaria CS Peptides," Science 240:800-802 (1988).
Lowell et al., "Proteosomes, Hydrophobic Anchors, Iscoms, and Liposomes for Improved Presentation of Peptide and Protein Vaccines,"in New Generation Vaccines, Woodrow and Levin, eds., New York: Marcel Dekker, Inc., pp. 141-160 (1990).
Marston A.O., "The purification of eukaryotic polypeptides synthezised in Escherichia coli," Biochem. J. 240:1-12 (1986).
McGuinness et al., "Deduced Amino Acid Sequences of Class 1 Protein (PorA) From Three Strains of Neisseria meningitidis," J. Exp. Med. 171:1871-1882 (1990).
Morona et al., "The nature of ompA mutants of Escherichia coli K12 exhibiting temperature-sensitive bacteriophage resistance," Mol. Gen. Genet. 201:357-359 (1985).
Murakami et al., "Cloning and Characterization of the Structural Gene for the Class 2 Protein of Neisseria menigitidis," Infect. Immun. 57:2318-2323 (1989).
Novagen Inc., Products Catalogue 1993: pET System, pp. 1, 36-47 (Novagen Inc., 597 Science drive, Madison, WI 537(1) (Dec. 1992).
Novagen Technical B
Blake Milan S.
Hronowski Lucjan J. J.
Liang Shu-Mei
Pullen Jeffrey K.
Qi Huilin L.
Housel James C.
North American Vaccine, Inc.
Shaver Jennifer
The Rockefeller University
LandOfFree
Method for the high level expression, purification and refolding does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the high level expression, purification and refolding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the high level expression, purification and refolding will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1317998